ASCO GU 2022 - ERLEADA ® Real-World Study in Metastatic Castration-Sensitive Prostate Cancer or mCS
21:07
Shrinking the Prostate for BPH | #MarkScholzMD #AlexScholz #ProstateCancer #PCRI
8:33
TITAN Phase 3 Trial with Apalutamide in Metastatic Castration Sensitive Prostate Cancer
31:13
TITAN Trial | Investigating the addition of apalutamide to androgen deprivation therapy
8:09
Comparing Apalutamide and Enzalutamide in Real-World Treatment of mCSPC
6:12
Apalutamide, ADT Improve Outcomes in High-Risk Prostate Cancer Post-Surgery
13:52
Metastatic #ProstateCancer Treatment Case Study | #MarkScholzMD #AlexScholz #PCRI
31:58
Nueva opción terapéutica para el cáncer de próstata #janssen #cancer #prostata #hormona
15:37